+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Inflammatory Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767757
  • Report
  • 119 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Gebro Pharma GmbH
  • GlaxoSmithKline Plc
  • Onorach Ltd
  • Pfizer Inc
  • MORE
The global clinical trial report- “2019 Inflammatory Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Inflammatory Pain. It presents in-depth analysis of Inflammatory Pain clinical trials across markets and companies. The research work is for providing complete understanding into trends in Inflammatory Pain.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Inflammatory Pain clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Inflammatory Pain

The research work is prepared through extensive and continuous research on Inflammatory Pain trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Inflammatory Pain patients are identified
  • The report includes panorama of Inflammatory Pain clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Inflammatory Pain clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Gebro Pharma GmbH
  • GlaxoSmithKline Plc
  • Onorach Ltd
  • Pfizer Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Inflammatory Pain Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Inflammatory Pain Clinical Trials by Region
2.2.2 Average Enrollment of Inflammatory Pain Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Inflammatory Pain Treatment, 2019

3. Region wise Inflammatory Pain Clinical Trials
3.1 Asia Pacific Inflammatory Pain Clinical Trials by Country
3.2 Europe Inflammatory Pain Clinical Trials by Country
3.3 North America Inflammatory Pain Clinical Trials by Country
3.4 Middle East and Africa Inflammatory Pain Clinical Trials by Country
3.5 South and Central America Inflammatory Pain Clinical Trials by Country

4. Inflammatory Pain Clinical Trial Trends
4.1 Start Year wise Inflammatory Pain Clinical Trials
4.2 Phase wise Inflammatory Pain Clinical Trials
4.3 Trial Status wise Inflammatory Pain Clinical Trials
4.4 Trial Type wise Inflammatory Pain Clinical Trials

5. Inflammatory Pain Average Enrollment Trends
5.1 Average Enrollment in Inflammatory Pain Trials by Year
5.2 Average Enrollment in Inflammatory Pain Trials by Phase
5.3 Average Enrollment in Inflammatory Pain Trials by Status
5.4 Average Enrollment in Inflammatory Pain Trials by Type of Trial

6. Companies Participating in Inflammatory Pain Clinical Trials
6.1 Inflammatory Pain Trials by Sponsor Type
6.2 Inflammatory Pain Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Inflammatory Pain Trials- Phase 1
7.2 Inflammatory Pain Trials- Phase 2
7.3 Inflammatory Pain Trials- Phase 3
7.4 Inflammatory Pain Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Inflammatory Pain Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Inflammatory Pain Clinical Trials and Enrolment
Figure 5: Europe - Country wise Inflammatory Pain Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Inflammatory Pain Clinical Trials and Enrolment
Figure 7: North America - Country wise Inflammatory Pain Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Inflammatory Pain Clinical Trials and Enrolment
Figure 9: Inflammatory Pain Clinical Trials by Phase
Figure 10: Inflammatory Pain Clinical Trials by Trial Status
Figure 11: Inflammatory Pain Clinical Trials by Type
Figure 12: Inflammatory Pain Clinical Trials by Sponsor Type
Figure 13: Inflammatory Pain Clinical Trials by Leading Sponsors
Figure 14: Inflammatory Pain Average Enrollment by Phase
Figure 15: Inflammatory Pain Average Enrollment by Trial Status
Figure 16: Inflammatory Pain Average Enrollment by Type
Figure 17: Inflammatory Pain- Average Enrolment by Type of Sponsors
Figure 18: Inflammatory Pain- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Inflammatory Pain Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Inflammatory Pain Clinical Trials and Enrolment
Table 5: Europe - Country wise Inflammatory Pain Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Inflammatory Pain Clinical Trials and Enrolment
Table 7: North America - Country wise Inflammatory Pain Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Inflammatory Pain Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Inflammatory Pain Average Enrollment by Phase
Table 15: Inflammatory Pain Average Enrollment by Trial Status
Table 16: Inflammatory Pain Average Enrollment by Type
Table 17: Inflammatory Pain- Average Enrolment by Type of Sponsors
Table 18: Inflammatory Pain- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bluefish Pharmaceuticals AB
  • C. H. Boehringer Sohn AG & Co KG
  • Centrexion Therapeutics Corp
  • Gebro Pharma GmbH
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Onorach Ltd
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Taro Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767757
Adroll
adroll